NNVC peer analysis
NanoViricides (NNVC) against its competitors: price, today's move, 1-year return and market value side by side.
- NNVC's peers: ANTX (AN2 Therapeutics), EVAX (Evaxion Biotech A/S), IGC (IGC Pharma), JSPR (Jasper Therapeutics), MAIA (MAIA Biotechnology), QTTB (Q32 Bio), SABS (SAB Biotherapeutics), TENX (Tenax Therapeutics).
NNVC and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ANTX AN2 Therapeutics | $5.22 | 5.45% | 383.33% | $198.07M |
| EVAX Evaxion Biotech A/S | $2.03 | -20.08% | -58.40% | $12.82M |
| IGC IGC Pharma | $0.18 | -5.45% | -43.56% | $21.47M |
| JSPR Jasper Therapeutics | $10.75 | -6.68% | -80.63% | $11.92M |
| MAIA MAIA Biotechnology | $1.14 | -12.31% | 23.91% | $70.40M |
| QTTB Q32 Bio | $8.18 | -3.54% | 285.85% | $244.78M |
| SABS SAB Biotherapeutics | $2.82 | -3.09% | -26.37% | $254.05M |
| TENX Tenax Therapeutics | $1.25 | -10.07% | -82.92% | $56.92M |
| VRCA Verrica Pharmaceuticals | $2.88 | 1.05% | -35.60% | $49.56M |
| NNVC NanoViricides | $1.17 | -1.68% | -17.02% | $29.90M |